4.8 Article

Endothelial cell clonal expansion in the development of cerebral cavernous malformations

期刊

NATURE COMMUNICATIONS
卷 10, 期 -, 页码 -

出版社

NATURE PUBLISHING GROUP
DOI: 10.1038/s41467-019-10707-x

关键词

-

资金

  1. Associazione Italiana per la Ricerca sul Cancro [AIRC IG 18683]
  2. AIRC 5x1000 call 'Metastatic disease: the key unmet need in oncology' [21267]
  3. Swedish Research Council [2013-9279]
  4. Knut and Alice Wallenberg Foundation
  5. European Research Council [742922]
  6. Initial Training Networks (ITN) Brain Barrier Training (BtRAIN) [675619]
  7. CARIPLO Foundation [2014-1038, 2016-0461]
  8. European Research Council (ERC) [742922] Funding Source: European Research Council (ERC)

向作者/读者索取更多资源

Cerebral cavernous malformation (CCM) is a neurovascular familial or sporadic disease that is characterised by capillary-venous cavernomas, and is due to loss-of-function mutations to any one of three CCM genes. Familial CCM follows a two-hit mechanism similar to that of tumour suppressor genes, while in sporadic cavernomas only a small fraction of endothelial cells shows mutated CCM genes. We reported that in mouse models and in human patients, endothelial cells lining the lesions have different features from the surrounding endothelium, as they express mesenchymal/stem-cell markers. Here we show that cavernomas originate from clonal expansion of few Ccm3-null endothelial cells that express mesenchymal/stem-cell markers. These cells then attract surrounding wild-type endothelial cells, inducing them to express mesenchymal/stem-cell markers and to contribute to cavernoma growth. These characteristics of Ccm3-null cells are reminiscent of the tumour-initiating cells that are responsible for tumour growth. Our data support the concept that CCM has benign tumour characteristics.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据